FI971734L - Beta, beta'-dihydroksi-menosubstituoidut kloriinit, isobakteriokloriinit, bakteriokloriinit ja menetelmä niiden valmistamiseksi beta, beta-substituoimattomista tetrapyrrolimakrosykleistä - Google Patents

Beta, beta'-dihydroksi-menosubstituoidut kloriinit, isobakteriokloriinit, bakteriokloriinit ja menetelmä niiden valmistamiseksi beta, beta-substituoimattomista tetrapyrrolimakrosykleistä Download PDF

Info

Publication number
FI971734L
FI971734L FI971734A FI971734A FI971734L FI 971734 L FI971734 L FI 971734L FI 971734 A FI971734 A FI 971734A FI 971734 A FI971734 A FI 971734A FI 971734 L FI971734 L FI 971734L
Authority
FI
Finland
Prior art keywords
beta
menosubstituted
isobacteriochlorins
bacteriochlorins
chlorins
Prior art date
Application number
FI971734A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971734A7 (fi
FI971734A0 (fi
Inventor
David Dolphin
Christian Bruckner
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Publication of FI971734L publication Critical patent/FI971734L/fi
Publication of FI971734A7 publication Critical patent/FI971734A7/fi
Publication of FI971734A0 publication Critical patent/FI971734A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
FI971734A 1994-10-26 1995-10-25 Beta, beta'-dihydroksi-menosubstituoidut kloriinit, isobakteriokloriinit, bakteriokloriinit ja menetelmä niiden valmistamiseksi beta, beta-substituoimattomista tetrapyrrolimakrosykleistä FI971734A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/329,577 US5648485A (en) 1994-10-26 1994-10-26 β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
PCT/CA1995/000602 WO1996013504A1 (fr) 1994-10-26 1995-10-25 CHLORINES, ISOBACTERIOCHLORINES, BACTERIOCHLORINES β,β'-DIHYDROXY MESO-SUBSTITUEES, ET LEURS PROCEDES DE FABRICATION A PARTIR DE MACROCYCLES TETRAPYRROLIQUES β,β' NON SUBSTITUES

Publications (3)

Publication Number Publication Date
FI971734L true FI971734L (fi) 1997-04-23
FI971734A7 FI971734A7 (fi) 1997-04-23
FI971734A0 FI971734A0 (fi) 1997-04-23

Family

ID=23286058

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971734A FI971734A0 (fi) 1994-10-26 1995-10-25 Beta, beta'-dihydroksi-menosubstituoidut kloriinit, isobakteriokloriinit, bakteriokloriinit ja menetelmä niiden valmistamiseksi beta, beta-substituoimattomista tetrapyrrolimakrosykleistä

Country Status (20)

Country Link
US (2) US5648485A (fr)
EP (1) EP0804439B1 (fr)
JP (2) JP3228296B2 (fr)
KR (1) KR970707129A (fr)
CN (1) CN1043143C (fr)
AT (1) ATE250064T1 (fr)
AU (1) AU704971B2 (fr)
CA (1) CA2199399C (fr)
CZ (1) CZ294496B6 (fr)
DE (1) DE69531795T2 (fr)
DK (1) DK0804439T3 (fr)
ES (1) ES2208701T3 (fr)
FI (1) FI971734A0 (fr)
HU (1) HU221102B1 (fr)
NO (1) NO308411B1 (fr)
NZ (1) NZ294203A (fr)
PL (1) PL182239B1 (fr)
PT (1) PT804439E (fr)
TW (1) TW301648B (fr)
WO (1) WO1996013504A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
GB9610967D0 (en) 1996-05-24 1996-07-31 Cambridge Antibody Tech Specific binding members,materials and methods
EP0973383A4 (fr) * 1997-01-21 2001-08-22 American Nat Red Cross Decontamination intracellulaire et extracellulaire de sang total et de composants du sang au moyen de colorants amphiphiles phenotiazin-5-ium et de lumiere
US6444194B1 (en) 1997-02-14 2002-09-03 Miravant Pharmaceuticals, Inc. Indium photosensitizers for PDT
FR2760841B1 (fr) * 1997-03-12 1999-04-16 Commissariat Energie Atomique Determination par resonance magnetique nucleaire de la configuration absolue d'amino-acides ou de leur derives et complexes metalliques de porphyrines chirales utilisables pour cette determination
DE19814405C2 (de) 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
US20030176663A1 (en) * 1998-05-11 2003-09-18 Eidgenossische Technische Hochscule Specific binding molecules for scintigraphy
HUP0104608A3 (en) 1998-10-20 2002-11-28 Procter & Gamble Tenzide mixture comprising modified alkylbenzene sulfonates and laundry detergents containing thereof, and process for preparation of the mixture and for use of the detergents
US6583096B1 (en) 1998-10-20 2003-06-24 The Procter & Gamble Company Laundry detergents comprising modified alkylbenzene sulfonates
US7022843B1 (en) 1999-04-14 2006-04-04 The University Of British Columbia β,β′-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
WO2000061584A1 (fr) * 1999-04-14 2000-10-19 The University Of British Columbia β,β'-DIHYDROXY CHLORES MESO-SUBSTITUES, ISOBACTERIOCHLORES, ET BACTERIOCHLORES AMELIORES
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US6376483B1 (en) 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
JP2003524018A (ja) 2000-02-24 2003-08-12 アイトゲネーシシェ テクニシェ ホッホシューレ チューリッヒ フィブロネクチンのｅｄ‐ｂドメインに特異的な抗体、前記抗体を含む複合体、および血管形成を検出および治療するためのその使用
CA2408323C (fr) 2000-05-08 2012-06-12 The University Of British Columbia Systemes d'apport de medicament, destines a une therapie photodynamique
CA2408332C (fr) 2000-05-08 2011-02-15 The University Of British Columbia Supports pour formulations photosensibilisantes
US6559374B2 (en) * 2000-07-21 2003-05-06 North Carolina State University Trans beta substituted chlorins and methods of making and using the same
CN1246333C (zh) * 2000-09-07 2006-03-22 舍林股份公司 EDb－纤粘连蛋白结构域(II)的受体
WO2002020536A1 (fr) * 2000-09-08 2002-03-14 San-Ei Gen F.F.I.,Inc. Derives de tetraphenyl-bacteriochlore et compositions les contenant
US20050090481A1 (en) * 2001-11-09 2005-04-28 Qlt Inc Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
EP1517684B1 (fr) 2002-06-27 2009-07-22 Health Research, Inc. Photosensibilisants fluores associes a des chlores et des bacteriochlores pour la therapie photodynamique
WO2004005289A2 (fr) * 2002-07-02 2004-01-15 Health Research, Inc. Synthese efficace de pyropheophorbide a et ses derives
EP1594875A4 (fr) * 2003-01-16 2007-07-11 Technomart Co Ltd Derives de porphyrine
US7057100B2 (en) * 2003-06-26 2006-06-06 The J.C. Robinson Seed Co. Inbred corn line W23129
GB0323358D0 (en) * 2003-10-06 2003-11-05 Green Grass Design Ltd Novel compounds and processes
JP4635493B2 (ja) * 2003-10-09 2011-02-23 日本製紙株式会社 ダル調塗工紙
GB2408265A (en) * 2003-11-21 2005-05-25 Univ Sheffield Water-soluble hyperbranched polymer porphyrins
US6995260B2 (en) * 2004-05-20 2006-02-07 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
WO2006089122A2 (fr) 2005-02-18 2006-08-24 North Carolina State University Nouvelle synthese de bacteriochlorines
WO2007064841A2 (fr) * 2005-11-30 2007-06-07 North Carolina State University Composes porphyriniques destines a une cytometrie de flux
WO2009038659A2 (fr) * 2007-09-14 2009-03-26 Health Research, Inc. Nanoparticules de silice organiquement modifiées avec des photosensibilisateurs incorporés par covalence pour l'administration de médicaments lors d'une thérapie photodynamique
US8253725B2 (en) * 2007-12-28 2012-08-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and system for generating surface models of geometric structures
US20120034155A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
ES2707228T3 (es) * 2008-09-18 2019-04-03 Biolitec Unternehmensbeteiligungs Ii Ag Nuevo método y aplicación de porfirinas y clorinas asimétricamente meso-sustituidas para TFD
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
US9226917B2 (en) 2008-12-16 2016-01-05 Valeant Pharmaceuticals International, Inc. Photodynamic therapy for conditions of the eye
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
JP5858932B2 (ja) 2010-02-04 2016-02-10 モルフォテック， インコーポレイテッド クロロトキシンポリペプチドおよびコンジュゲートならびにその使用
JP2013532664A (ja) * 2010-07-22 2013-08-19 セラムオプテック ゲゼルシャフト ミット ベシュレンクテル ハフツング ＰＤＴのためのβ−官能化ジヒドロキシ−クロリンの用途
WO2013003507A1 (fr) 2011-06-27 2013-01-03 Morphotek, Inc. Agents multifonction
JP6181059B2 (ja) 2011-10-25 2017-08-16 メモリアル スローン−ケタリング キャンサー センター 前立腺がんのための診断薬、予後判定薬、および治療薬としてのフリーｐｓａ抗体
AU2013334102B2 (en) 2012-10-26 2018-08-16 Memorial Sloan-Kettering Cancer Center Modulators of resistant androgen receptor
CA2907356C (fr) 2013-03-15 2022-07-12 Sherri Ann MCFARLAND Complexes de coordination a base de metal en tant que composes photodynamiques et leur utilisation
PL3087182T3 (pl) 2013-12-23 2019-11-29 Memorial Sloan Kettering Cancer Center Sposoby i kompozycje do leczenia raka wykorzystujące środki oparte na kwasie peptydonukleinowym
TWI474536B (zh) 2014-07-01 2015-02-21 Nat Univ Chung Hsing 紫質光敏染料化合物以及染料敏化太陽能電池
EP3201201B1 (fr) 2014-09-30 2022-01-26 biolitec unternehmensbeteiligungs II AG Porphyrines et chlores méso-substitués de façon spécifique pour la thérapie photodynamique
RU2615770C1 (ru) * 2015-12-21 2017-04-11 Общество с ограниченной ответственностью "Пермская химическая компания" Борированные производные фторированных бактериохлоринов и их металлокомплексов, обладающие противоопухолевой активностью
CA3045921C (fr) * 2016-12-05 2024-06-04 Salt And Light Pharmaceuticals Pty. Ltd. Composes therapeutiques photodynamiques et procedes de traitement photodynamique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US6376483B1 (en) * 1999-05-27 2002-04-23 Miravant Pharmaceuticals, Inc. Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production

Also Published As

Publication number Publication date
CA2199399C (fr) 2004-02-24
CN1043143C (zh) 1999-04-28
NZ294203A (en) 1998-12-23
PT804439E (pt) 2004-02-27
JP3228296B2 (ja) 2001-11-12
US5831088A (en) 1998-11-03
CZ294496B6 (cs) 2005-01-12
PL182239B1 (pl) 2001-11-30
NO308411B1 (no) 2000-09-11
ATE250064T1 (de) 2003-10-15
CZ115597A3 (en) 1997-09-17
EP0804439B1 (fr) 2003-09-17
AU704971B2 (en) 1999-05-13
JPH10507766A (ja) 1998-07-28
TW301648B (fr) 1997-04-01
CA2199399A1 (fr) 1996-05-09
HU221102B1 (en) 2002-08-28
FI971734A7 (fi) 1997-04-23
JP2001294589A (ja) 2001-10-23
ES2208701T3 (es) 2004-06-16
NO971952D0 (no) 1997-04-25
MX9703013A (es) 1997-07-31
HUT77008A (hu) 1998-03-02
PL319907A1 (en) 1997-09-01
WO1996013504A1 (fr) 1996-05-09
FI971734A0 (fi) 1997-04-23
NO971952L (no) 1997-04-25
DE69531795T2 (de) 2004-08-05
US5648485A (en) 1997-07-15
AU3695195A (en) 1996-05-23
DK0804439T3 (da) 2004-02-02
KR970707129A (ko) 1997-12-01
EP0804439A1 (fr) 1997-11-05
CN1161697A (zh) 1997-10-08
DE69531795D1 (de) 2003-10-23

Similar Documents

Publication Publication Date Title
FI971734L (fi) Beta, beta'-dihydroksi-menosubstituoidut kloriinit, isobakteriokloriinit, bakteriokloriinit ja menetelmä niiden valmistamiseksi beta, beta-substituoimattomista tetrapyrrolimakrosykleistä
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
ZA948592B (en) 7H-imidazo[1,2-a]pyrazin-8-one derivatives,and their preparation and use
HUP9800725A3 (en) 4-benzoyl-pyrozol derivatives, process for their preparation and their use as herbicides
DE69122687D1 (de) Cellulase, Verfahren zu deren Herstellung und deren Verwendung
AU1106195A (en) Heterocyclic compounds, their preparation and use
DE69523875D1 (de) N-aryl[1,2,4]triazolo[1,5-a]pyridin-2-sulfonamide herbizide
AU4278400A (en) Improved beta,beta,-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
FI922848L (fi) Menetelmä valmistaa terapeuttisesti aktiivisia tetrahydropyrrolo[1,2-a]pyratsiini-4-spiro-3'-pyrrolidiinijohdannaisia
AU3244797A (en) Indanylidene compounds, a process for their preparation and their use as UV absorbers
CZ2019997A3 (cs) Deriváty pyridazino [4,5-B] chinolin-5-oxidu, způsob jejich přípravy a jejich použití jako antagonistů glycinu
EE9900155A (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetod ja kasutamine raviks
FI971310L (fi) 2,7-substituoituja oktahydro-1H-pyrido/1,2-a/pyratsiinijohdannaisia
DE59712148D1 (de) 1,3-dimethyl-5-fluor-pyrazol-4-carboxamide derivative, deren herstellung und deren verwendung als mikrobizide
AU7634896A (en) Substituted porphyrins
AU2243297A (en) Core structure for blood oxygenators
DE59402216D1 (de) Fullerenderivate, Verfahren zur Herstellung und deren Verwendung
DE69532405D1 (de) 1H-Pyrrolo [1,2-b][1,2,4] triazol-Derivate und deren Herstellung über 1H-1,2,4-triazol-Derivate
FI971075L (fi) (1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
ZA918452B (en) Triazolopyridazine derivatives
EP0527441A3 (en) Water-soluble phthalocyanine dyes, process for their preparation and their use
AU3698795A (en) Naphthyridine derivatives
FI971076L (fi) (1,2,4)triatsolo (4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
FI20011154L (fi) Välituotteena käyttökelpoiset tiatsolo(3,2-a)atsepiinijohdannaiset ja menetelmä niiden valmistamiseksi
AU7673991A (en) Method for treating fungal infection

Legal Events

Date Code Title Description
FD Application lapsed